Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;36(1):236-243.
doi: 10.1111/jocs.15213. Epub 2020 Nov 22.

Management of cardiovascular diseases in HIV/AIDS patients

Santoshi K Ashwitha  1 , Preethi A Jacob  1 , Abdullah Ajaj  1 , Manasi M Shirke  1 , Amer Harky  2   3   4
Affiliations
Review

Management of cardiovascular diseases in HIV/AIDS patients

Santoshi K Ashwitha et al. J Card Surg. 2021 Jan.

Abstract

Human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome, a pandemic in the current population causes severe weakness of the body's immune system making the infected patient more vulnerable to life-threatening conditions. The disease predisposes the infected patient to several cardiovascular diseases and cerebrovascular diseases such as heart failure and stroke. The decline in CD4 cells following HIV infection, vulnerability to opportunistic infections and underlying HIV pathology plays a major role in the development of cardiovascular manifestations, and treatment targeting cardiomyopathy in this specific patient subset is not well recognized. Patients living with HIV (PLWH) also experience discrimination in receiving cardiovascular disease care and this needs to be addressed by strengthening frameworks for monitoring and providing nonjudgmental healthcare. This review aims to study the profile of the cardiovascular disease in HIV patients, treatment, and provide evidence of the disparity in the provision of healthcare with regard to PLWH.

Keywords: cardiovascular disease; heart; immunodeficiency; immunosuppression.

PubMed Disclaimer

References

REFERENCES

    1. Fajardo-Ortiz D, Lopez-Cervantes M, Duran L, et al. The emergence and evolution of the research fronts in HIV/AIDS research. PLoS One. 2017;12(5):e0178293. https://doi.org/10.1371/journal.pone.0178293
    1. Nou E, Lo J, Hadigan C, Grinspoon SK. Pathophysiology and management of cardiovascular disease in patients with HIV. Lancet Diabetes Endocrinol. 2016;4(7):598-610. https://doi.org/10.1016/S2213-8587(15)00388-5
    1. Global AIDS update 2016. Joint United Nations Programme on HIV/AIDS; 2016. http://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016 Accessed October 10, 2020.
    1. Eckard AR, Meissner EG, Singh I, McComsey GA. Cardiovascular disease, statins, and HIV. J Infect Dis. 2017;215:496. https://doi.org/10.1093/infdis/jiw288
    1. Francula-Zaninovic S, Nola IA. Management of measurable variable cardiovascular disease' risk factors. Curr Cardiol Rev. 2018;14(3):153-163. https://doi.org/10.2174/1573403X14666180222102312

MeSH terms